
Prescription Drug Name:
ATENOLOL TABLETS USP, 0752, Rx only
ID:
61e1c13a-235f-e435-e053-2a91aa0a8c0b
Code:
34391-3
DESCRIPTION
id: 61e1c13a-237a-e435-e053-2a91aa0a8c0b
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
1-selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as benzeneacetamide, 4-[2′-hydroxy-3′-[(1-methylethyl) amino] propoxy]-. The molecular and structural formulas are:
14H
22N
2O
3 M.W. (free base) 266.34
CLINICAL PHARMACOLOGY
id: 61e1c13a-237b-e435-e053-2a91aa0a8c0b
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
1-selective (cardioselective) beta-adrenergic receptor blocking agent without membrane stabilizing or intrinsic sympathomimetic (partial agonist) activities. This preferential effect is not absolute, however, and at higher doses, atenolol inhibits beta
2-adrenoreceptors, chiefly located in the bronchial and vascular musculature.
CONTRAINDICATIONS
id: 61e1c13a-237d-e435-e053-2a91aa0a8c0b
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
ADVERSE REACTIONS
id: 61e1c13a-2380-e435-e053-2a91aa0a8c0b
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
|
(Foreign + U.S. Studies) |
|||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
POTENTIAL ADVERSE EFFECTS
id: 61e1c13a-2381-e435-e053-2a91aa0a8c0b
displayName: SPL UNCLASSIFIED SECTION
FDA Article Code: 42229-5
OVERDOSAGE
id: 61e1c13a-2388-e435-e053-2a91aa0a8c0b
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5
2 stimulant such as isoproterenol or terbutaline and/or aminophylline.
HOW SUPPLIED
id: 61e1c13a-238a-e435-e053-2a91aa0a8c0b
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
Package/Label Display Panel
id: 61e1e5c9-5540-06f8-e053-2991aa0ab29d
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4